Anatara Lifesciences (ASX:ANR) Announces Phase II GaRP-IBS Trial Results
Anatara Lifesciences (ASX:ANR) reports Phase II GaRP-IBS trial results, highlighting safety and significant improvements in anxiety scores.
Anatara Lifesciences (ASX:ANR) reports Phase II GaRP-IBS trial results, highlighting safety and significant improvements in anxiety scores.
Dreadnought Resources Ltd (ASX:DRE) closes its Share Purchase Plan, raising $1.73M with strong shareholder support.
West African Resources Limited (ASX:WAF) releases its quarterly cash flow report, highlighting key operational and financial metrics.
Tourism Holdings Limited (ASX:THL) updates FY25 trading outlook, projecting lower NPAT due to decreased bookings and vehicle sales demand.
Pilbara Minerals (ASX:PLS) reports March quarter production of 125 kt, reduced revenue, and key project completions.
Mighty Kingdom Limited (ASX:MKL) issues a replacement prospectus for a non-renounceable entitlement offer, aiming to raise up to $1.08M to support operational growth and profitability.
BHP (ASX:BHP) achieves record copper and iron ore production in FY25, showcasing business resilience and strategic growth initiatives.
Challenger Limited (ASX:CGF) reports Q3 revenue growth in annuity sales and maintains strong capitalisation.
Bank of Queensland Limited (ASX:BOQ) reports a 6% increase in cash earnings and a 13% rise in statutory profits for the first half of 2025.
Heartland Group (ASX:HGH) reports a strong Q3 with significant receivables growth and improved asset quality.